Marijuana has long carried a negative stigma, but thanks to recent studies confirming its ability to treat many afflictions, including chronic neuropathic pain, it is becoming more socially acceptable. In September the Foundation for Peripheral Neuropathy held their highly acclaimed 2016 FPN International Research Symposium, attended by some of the world’s leading research scientists and neurologists in the forefront of neuropathic pain research. Because of promising studies confirming medical marijuana’s ability to relieve neuropathic pain, the Foundation devoted eight separate presentations to medical marijuana and its implications in treating neuropathic pain, as well as to regulatory, industry, and medical perspectives. The Foundation for Peripheral Neuropathy also includes information on medical marijuana on the FPN blog.